Results for tag: "Mineral Metabolism Disorder Drug"

The Mineral Metabolism Disorder Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. These drugs are used to treat mineral metabolism disorders, which are caused by an imbalance of minerals in the body. These drugs are used to restore the balance of minerals in the body, such as calcium, phosphorus, and magnesium. They are also used to treat conditions such as hypoparathyroidism, hyperparathyroidism, and hypomagnesemia. These drugs are available in both oral and injectable forms. The Mineral Metabolism Disorder Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. These companies are continuously developing new drugs and therapies to meet the needs of patients with mineral metabolism disorders. Show Less Read more